Please use this identifier to cite or link to this item:
|Title:||Structural features and bleeding activity of commercial low molecular weight heparins: Neutralization by ATP and protamine|
|Authors:||Dietrich, Carl Peter|
Shinjo, S. T.
Moraes, F. A.
Gouvea, T. C.
Nader, Helena Boncini. [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
low molecular weight heparin
|Publisher:||Thieme Medical Publ Inc|
|Citation:||Seminars In Thrombosis And Hemostasis. New York: Thieme Medical Publ Inc, v. 25, n. suppl 3, p. 43-50, 1999.|
|Abstract:||Differences in the structure of three low molecular weight heparins (LMWHs) have been observed by applying physico-chemical methods as well as enzymatic degradation with bacterial heparinase and heparitinase II. The production of enoxaparin maintains the internal structure of the parent heparin with the exception of the unsaturated nonreducing end. In contrast, the production of dalteparin and nadroparin removes part of their nonsulfated uronic acid residues and, unlike enoxaparin and unfractionated heparin (UFH), these LMWHs also contain regions that remain resistant to the action of heparitinase II. Enoxaparin has a lower molecular weight distribution than dalteparin and nadroparin and is composed of at least four discrete molecular weight populations. A rat-tail model demonstrated that LMWHs applied topically or injected intravenously had a lower bleeding potency when compared with UFH treatment. The bleeding potencies of the different LMWHs were similar. Furthermore, adenosine triphosphate (ATP) completely neutralized bleeding caused by LMWHs and UFH in the animal model when applied topically and significantly reduced bleeding in heparinized surgical patients undergoing cardiopulmonary bypass surgery.|
|Appears in Collections:||Artigo|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.